Brain-Computer Interface Developer Announces Entry to Clinical Trials for Its Implants in the US; FDA Authorizes Test of Device in Human Patients Medicine & Technology Jul 29, 2021 Brain-Computer interface company, Synchron received approval from the FDA for its clinical trials in the US. Specifically, the BCI developer will place its Stentrode device in the brain to help paralyzed patients.
Project Hephaistos: Scientists Claim To Have Detected Technosignatures From Dyson Spheres of Alien Civilization
SPACE NASA's Juno Mission Releases New Photos Featuring Great Red Spot, Potato-Like Shape Moon Amalthea